Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter randomized trial

Pulmonary intravascular thrombus formation has been widely observed in patients with respiratory failure, for example, in patients with SARS-CoV-2 infection (COVID-19). The aim of this study was to evaluate the efficacy/safety of alteplase thrombolysis in COVID-19 severe hypoxemic respiratory failur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Landoni, Giovanni (VerfasserIn) , Chowdary, Pratima (VerfasserIn) , Meziani, Ferhat (VerfasserIn) , Creteur, Jacques (VerfasserIn) , De Schryver, Nicolas (VerfasserIn) , Motsch, Johann (VerfasserIn) , Henrichmoeller, Ingrid (VerfasserIn) , Pagès, Alain (VerfasserIn) , Peter, Nuala (VerfasserIn) , Danays, Thierry (VerfasserIn) , Weigand, Markus A. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 10 November 2024
In: Annals of intensive care
Year: 2024, Jahrgang: 14, Heft: 1, Pages: 1-13
ISSN:2110-5820
DOI:10.1186/s13613-024-01386-z
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13613-024-01386-z
Verlag, kostenfrei, Volltext: https://annalsofintensivecare.springeropen.com/articles/10.1186/s13613-024-01386-z
Volltext
Verfasserangaben:Giovanni Landoni, Pratima Chowdary, Ferhat Meziani, Jacques Creteur, Nicolas De Schryver, Johann Motsch, Ingrid Henrichmoeller, Alain Pagès, Nuala Peter, Thierry Danays, and Markus A. Weigand, on behalf of the TRISTARDS Investigators

MARC

LEADER 00000caa a2200000 c 4500
001 1923551191
003 DE-627
005 20250717011431.0
007 cr uuu---uuuuu
008 250424s2024 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13613-024-01386-z  |2 doi 
035 |a (DE-627)1923551191 
035 |a (DE-599)KXP1923551191 
035 |a (OCoLC)1528044959 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Landoni, Giovanni  |e VerfasserIn  |0 (DE-588)1232749206  |0 (DE-627)1757055312  |4 aut 
245 1 0 |a Alteplase in COVID-19 severe hypoxemic respiratory failure  |b the TRISTARDS multicenter randomized trial  |c Giovanni Landoni, Pratima Chowdary, Ferhat Meziani, Jacques Creteur, Nicolas De Schryver, Johann Motsch, Ingrid Henrichmoeller, Alain Pagès, Nuala Peter, Thierry Danays, and Markus A. Weigand, on behalf of the TRISTARDS Investigators 
264 1 |c 10 November 2024 
300 |b Illustrationen 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 24.04.2025 
520 |a Pulmonary intravascular thrombus formation has been widely observed in patients with respiratory failure, for example, in patients with SARS-CoV-2 infection (COVID-19). The aim of this study was to evaluate the efficacy/safety of alteplase thrombolysis in COVID-19 severe hypoxemic respiratory failure. In this multicenter, open-label study, patients were randomized to receive alteplase (low- or high-dose) over 5 days plus standard of care (SOC), or SOC alone. The primary endpoint was time to clinical improvement (≥ 2-point decrease on WHO Clinical Progression Scale, or hospital discharge) up to Day 28. Secondary endpoints included all-cause mortality at Day 28, treatment failure at Day 28 and change in arterial oxygen partial pressure/fractional inspired oxygen (PaO2/FiO2) ratio at Day 6 versus baseline. 
650 4 |a Alteplase 
650 4 |a ARDS 
650 4 |a COVID-19 
650 4 |a Severe hypoxemic respiratory failure 
650 4 |a Thrombolysis 
700 1 |a Chowdary, Pratima  |e VerfasserIn  |4 aut 
700 1 |a Meziani, Ferhat  |e VerfasserIn  |4 aut 
700 1 |a Creteur, Jacques  |e VerfasserIn  |4 aut 
700 1 |a De Schryver, Nicolas  |e VerfasserIn  |4 aut 
700 1 |a Motsch, Johann  |d 1952-  |e VerfasserIn  |0 (DE-588)1059446626  |0 (DE-627)798468319  |0 (DE-576)415532876  |4 aut 
700 1 |a Henrichmoeller, Ingrid  |e VerfasserIn  |4 aut 
700 1 |a Pagès, Alain  |e VerfasserIn  |4 aut 
700 1 |a Peter, Nuala  |e VerfasserIn  |4 aut 
700 1 |a Danays, Thierry  |e VerfasserIn  |4 aut 
700 1 |a Weigand, Markus A.  |d 1967-  |e VerfasserIn  |0 (DE-588)1064970435  |0 (DE-627)815375239  |0 (DE-576)424658666  |4 aut 
773 0 8 |i Enthalten in  |t Annals of intensive care  |d Heidelberg : Springer, 2011  |g 14(2024), 1, Artikel-ID 170, Seite 1-13  |h Online-Ressource  |w (DE-627)664260918  |w (DE-600)2617094-2  |w (DE-576)347284760  |x 2110-5820  |7 nnas  |a Alteplase in COVID-19 severe hypoxemic respiratory failure the TRISTARDS multicenter randomized trial 
773 1 8 |g volume:14  |g year:2024  |g number:1  |g elocationid:170  |g pages:1-13  |g extent:13  |a Alteplase in COVID-19 severe hypoxemic respiratory failure the TRISTARDS multicenter randomized trial 
856 4 0 |u https://doi.org/10.1186/s13613-024-01386-z  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://annalsofintensivecare.springeropen.com/articles/10.1186/s13613-024-01386-z  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250424 
993 |a Article 
994 |a 2024 
998 |g 1064970435  |a Weigand, Markus A.  |m 1064970435:Weigand, Markus A.  |d 910000  |d 910300  |e 910000PW1064970435  |e 910300PW1064970435  |k 0/910000/  |k 1/910000/910300/  |p 11  |y j 
998 |g 1059446626  |a Motsch, Johann  |m 1059446626:Motsch, Johann  |d 50000  |e 50000PM1059446626  |k 0/50000/  |p 6 
999 |a KXP-PPN1923551191  |e 4709695784 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","family":"Landoni","display":"Landoni, Giovanni","given":"Giovanni"},{"role":"aut","display":"Chowdary, Pratima","given":"Pratima","family":"Chowdary"},{"role":"aut","given":"Ferhat","display":"Meziani, Ferhat","family":"Meziani"},{"family":"Creteur","given":"Jacques","display":"Creteur, Jacques","role":"aut"},{"display":"De Schryver, Nicolas","given":"Nicolas","family":"De Schryver","role":"aut"},{"role":"aut","family":"Motsch","display":"Motsch, Johann","given":"Johann"},{"given":"Ingrid","display":"Henrichmoeller, Ingrid","family":"Henrichmoeller","role":"aut"},{"role":"aut","given":"Alain","display":"Pagès, Alain","family":"Pagès"},{"role":"aut","family":"Peter","display":"Peter, Nuala","given":"Nuala"},{"role":"aut","given":"Thierry","display":"Danays, Thierry","family":"Danays"},{"display":"Weigand, Markus A.","given":"Markus A.","family":"Weigand","role":"aut"}],"name":{"displayForm":["Giovanni Landoni, Pratima Chowdary, Ferhat Meziani, Jacques Creteur, Nicolas De Schryver, Johann Motsch, Ingrid Henrichmoeller, Alain Pagès, Nuala Peter, Thierry Danays, and Markus A. Weigand, on behalf of the TRISTARDS Investigators"]},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"10 November 2024"}],"recId":"1923551191","title":[{"subtitle":"the TRISTARDS multicenter randomized trial","title_sort":"Alteplase in COVID-19 severe hypoxemic respiratory failure","title":"Alteplase in COVID-19 severe hypoxemic respiratory failure"}],"language":["eng"],"physDesc":[{"extent":"13 S.","noteIll":"Illustrationen"}],"id":{"doi":["10.1186/s13613-024-01386-z"],"eki":["1923551191"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 24.04.2025"],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.2011 -"],"recId":"664260918","disp":"Alteplase in COVID-19 severe hypoxemic respiratory failure the TRISTARDS multicenter randomized trialAnnals of intensive care","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"issue":"1","extent":"13","pages":"1-13","year":"2024","volume":"14","text":"14(2024), 1, Artikel-ID 170, Seite 1-13"},"id":{"zdb":["2617094-2"],"issn":["2110-5820"],"eki":["664260918"]},"note":["Gesehen am 04.06.2020"],"origin":[{"publisherPlace":"Heidelberg","dateIssuedKey":"2011","dateIssuedDisp":"2011-","publisher":"Springer"}],"title":[{"title_sort":"Annals of intensive care","title":"Annals of intensive care"}]}]} 
SRT |a LANDONIGIOALTEPLASEI1020